Cubist Systematic Strategies LLC cut its holdings in shares of Constellium SE (NYSE:CSTM - Free Report) by 57.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 221,986 shares of the industrial products company's stock after selling 302,572 shares during the period. Cubist Systematic Strategies LLC owned 0.15% of Constellium worth $2,280,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. raised its position in shares of Constellium by 26.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 19,828,738 shares of the industrial products company's stock valued at $203,642,000 after acquiring an additional 4,181,823 shares during the period. Nut Tree Capital Management LP raised its position in shares of Constellium by 52.8% in the 4th quarter. Nut Tree Capital Management LP now owns 5,500,000 shares of the industrial products company's stock valued at $56,485,000 after acquiring an additional 1,900,000 shares during the period. Thrivent Financial for Lutherans raised its position in shares of Constellium by 242.7% in the 4th quarter. Thrivent Financial for Lutherans now owns 1,522,400 shares of the industrial products company's stock valued at $15,636,000 after acquiring an additional 1,078,196 shares during the period. Bridgeway Capital Management LLC acquired a new stake in shares of Constellium in the 4th quarter valued at approximately $8,615,000. Finally, Capstone Investment Advisors LLC acquired a new stake in shares of Constellium in the 4th quarter valued at approximately $7,138,000. 92.59% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft upgraded shares of Constellium from a "hold" rating to a "buy" rating and set a $15.00 price target on the stock in a research report on Tuesday, February 25th.
Read Our Latest Analysis on Constellium
Constellium Stock Down 2.5%
NYSE CSTM traded down $0.31 during trading hours on Friday, reaching $11.78. 2,127,569 shares of the company's stock were exchanged, compared to its average volume of 1,436,553. The company's 50-day moving average is $10.18 and its two-hundred day moving average is $10.63. Constellium SE has a one year low of $7.33 and a one year high of $22.00. The company has a debt-to-equity ratio of 1.93, a quick ratio of 0.52 and a current ratio of 1.28. The company has a market capitalization of $1.68 billion, a price-to-earnings ratio of 36.80 and a beta of 1.65.
Constellium (NYSE:CSTM - Get Free Report) last posted its earnings results on Wednesday, April 30th. The industrial products company reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.07 by $0.19. Constellium had a return on equity of 4.83% and a net margin of 0.67%. The business had revenue of $1.98 billion during the quarter, compared to analysts' expectations of $1.88 billion. During the same period in the prior year, the business earned $0.11 EPS. Constellium's revenue for the quarter was up 5.3% compared to the same quarter last year. On average, analysts forecast that Constellium SE will post 1.1 EPS for the current fiscal year.
Constellium Company Profile
(
Free Report)
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
Recommended Stories

Before you consider Constellium, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Constellium wasn't on the list.
While Constellium currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.